Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gabrielle Scheuber
Institutions:
Medical College of Wisconsin,
Medical College of Wisconsin Cancer Center
Observed institutions:
Medical College of Wisconsin,
Medical College of Wisconsin Cancer Center
ORCID:
0009-0006-5258-8258
Observed ORCID:
0009-0006-5258-8258
OpenAlex ID:
A5140417720
Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
2026
·
Daniel Dorbin
, Juliannie Herrera
, et al.
·
Cancer Research
·
4
PDF
Figure S2 from Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
2026
·
Daniel Dorbin
, Juliannie Herrera
, et al.
Figure S4 from Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
2026
·
Daniel Dorbin
, Juliannie Herrera
, et al.
Figure S1 from Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
2026
·
Daniel Dorbin
, Juliannie Herrera
, et al.
Data from Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
2026
·
Daniel Dorbin
, Juliannie Herrera
, et al.
Figure S6 from Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
2026
·
Daniel Dorbin
, Juliannie Herrera
, et al.
Figure S3 from Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
2026
·
Daniel Dorbin
, Juliannie Herrera
, et al.
Figure S5 from Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
2026
·
Daniel Dorbin
, Juliannie Herrera
, et al.
Abstract B123: Oncostatin M receptor (OSMR) is a tumor-selective target in pancreatic ductal adenocarcinoma: Quantitative expression in primary and metastatic patient tumors
2026
·
Naveenkumar Chandrashekhar
, Edward Opichka
, et al.
·
Cancer Research
Beyond BRCAness: ATM pathway defects confer sensitivity to topoisomerase I inhibition
2026
·
Mandana Kamgar
, Thomas McFall
, et al.
·
Genome Medicine
Show more works
View as search
Works count:
10
Citation count:
4
H-index:
1
I10-index:
Year
Topic
Type